Clinical study of insulin aspart in the treatment of gestational diabetes
门冬胰岛素治疗妊娠糖尿病的临床研究

摘要

目的 分析门冬胰岛素治疗妊娠糖尿病效果。方法 研究时间：2020年9月-2022年8月，研究对象：本院收治的70例妊娠糖尿病患者，分组方法：随机分组。对照组采取常规护理，观察组结合门冬胰岛素治疗，对比血糖控制效果、妊娠结局等指标。结果 观察组治疗后血糖控制水平低于对照组（P<0.05）；观察组血糖控制时间较对照组早，胰岛素用量更少，低血糖发生率更低（P<0.05）；观察组不良妊娠结局比例低于对照组（P<0.02）；观察组用药无不良反应，对照组仅发生1例尿路感染。结论 门冬胰岛素的应用，对妊娠糖尿病患者血糖控制效果好，血糖控制时间早，胰岛素用量少，可降低低血糖不良反应。在门冬胰岛素应用下，患者获得了较好的妊娠结局，用药安全性也得到充分保证。

Abstract

Objective To analyze the effect of insulin aspart in the treatment of gestational diabetes.
Methods The study time was from September 2020 to August 2022. The study subjects were 70 patients with gestational diabetes admitted to our hospital. The grouping method was randomized. The control group was given routine nursing care, and the observation group was treated with aspartic insulin to compare the effect of blood glucose control and pregnancy outcome.
Results The blood glucose control level in the observation group was lower than that in the control group after treatment (P<0.05); The blood glucose control time of the observation group was earlier than that of the control group, the amount of insulin was less, and the incidence of hypoglycemia was lower (P<0.05); The proportion of adverse pregnancy outcome in the observation group was lower than that in the control group (P<0.05); There was no adverse reaction in the observation group, and only one case of urinary tract infection occurred in the control group.
Conclusion   The application of insulin aspart has a good effect on the blood sugar control of pregnant diabetes patients. The blood sugar control time is early, the amount of insulin is small, and the adverse reaction of hypoglycemia can be reduced. With the application of aspartic insulin, the patient achieved a better pregnancy outcome, and the safety of medication was fully guaranteed.